Health & Behavior

Research

The Latest

New Reprogramming Method Makes Better Stem Cells

A team of researchers from the University of California, San Diego School of Medicine, Oregon Health & Science University (OHSU) and Salk Institute for Biological Studies has shown for the first time that stem cells created using different methods produce differing cells. The findings, published in the July 2, 2014 online issue of Nature, provide new insights into the basic biology of stem cells and could ultimately lead to improved stem cell therapies.

Upending a Cancer Dogma

Researchers at the University of California, San Diego School of Medicine say a protein essential to regulating cell cycle progression – the process of cell division and replication – activates a key tumor suppressor, rather than inactivating it as previously thought.

Biomarker Predicts Effectiveness of Brain Cancer Treatment

Researchers at the University of California, San Diego School of Medicine have identified a new biomarker that predicts whether glioblastoma – the most common form of primary brain cancer – will respond to chemotherapy. The findings are published in the July print issue of Oncotarget.

McKerrow Appointed Dean of Skaggs School of Pharmacy and Pharmaceutical Sciences

Effective July 1, 2014, James H. McKerrow, MD, PhD, will become the second dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. McKerrow will join UC San Diego from UC San Francisco, where he served as professor of pathology and director of the Center for Discovery and Innovation in Parasitic Diseases.

Marine Bacteria Are Natural Source of Chemical Fire Retardants

Researchers at the University of California, San Diego School of Medicine have discovered a widely distributed group of marine bacteria that produce compounds nearly identical to toxic man-made fire retardants.

Felipe Medeiros Appointed to UC San Diego Hildyard Chair for Diseases of the Eye

Glaucoma specialist Felipe Medeiros, MD, PhD, professor of clinical ophthalmology and medical director of the Hamilton Glaucoma Center at the University of California, San Diego Shiley Eye Center, has been named the inaugural holder of the Ben and Wanda Hildyard Chair for Diseases of the Eye. The chair is one of three established by a bequest from Ben and Wanda Hildyard to help UC San Diego School of Medicine recruit and retain top faculty members. The bequest provided endowment funds of more than $6 million to establish the three chairs.